Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0SV8E
|
||||
| Drug Name |
Methotrexate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Leukemia [ICD10:C91-C95] | Approved | [1] | ||
| Cancer [ICD10:C00-D49] | Phase 3 | [1] | |||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H22N8O5
|
||||
| PubChem Compound ID | |||||
| Drug Resistance Mutation (DRM) | |||||
| DRM | DRM Info | ||||
| References | |||||
| REF 1 | Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.